Comparing the Effect of Melatonin, Diazepam, and Placebo on Decreasing the Level of Anxiety Preoperatively

Sponsor
University of Jordan (Other)
Overall Status
Completed
CT.gov ID
NCT06103188
Collaborator
(none)
87
1
3
17
155.8

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the effect of melatonin, diazepam, and placebo on the level of anxiety in patients undergoing surgery. The main question it aims to answer is:

• Is melatonin effective in reducing the anxiety of patients undergoing surgery? Participants will be asked to answer a questionnaire then they will receive either melatonin, diazepam, or placebo, and then after an hour, they will answer the same questionnaire again.

Researchers will compare melatonin, diazepam, and placebo to see if melatonin is as effective in reducing the level of anxiety as diazepam in patients undergoing surgery.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

Anxiety is a tense unpleasant sensation experienced by many individuals secondary to their concerns or due to the anticipation of an unpleasant experience like a surgery. Even with the advancement of medical treatment, preoperative anxiety remains a widespread complaint that affects the patients psychologically and physically, and at the same time adversely affecting the outcome of the operation and the experience of the patient.

In this triple-blind, randomized clinical study, we aim to compare melatonin to diazepam regarding its efficacy in reducing preoperative anxiety, as well as assessing multiple other effects such as sedation, orientation, and cognition, by applying validated tools to patients undergoing elective surgeries before and after administering the premedication.

Study Design

Study Type:
Interventional
Actual Enrollment :
87 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparing Melatonin to Diazepam as a Premedication: a Triple-blind, Randomized, Placebo Controlled Clinical Trial
Actual Study Start Date :
Oct 2, 2023
Actual Primary Completion Date :
Oct 19, 2023
Actual Study Completion Date :
Oct 19, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo

A 5mg vitamin B12 pill

Drug: Placebo
The placebo pill will be given to the patients 1 hour prior to their planned surgery.

Active Comparator: Diazepam

A 5mg diazepam pill

Drug: Diazepam
Diazepam will be given to the patients 1 hour prior to their planned surgery.

Experimental: Melatonin

A 5mg melatonin pill

Drug: Melatonin
Melatonin will be given to the patients 1 hour prior to their planned surgery.

Outcome Measures

Primary Outcome Measures

  1. Change in the anxiety score using the visual analogue score for anxiety between treatment arms [Before administration of premedication, and after 1 hour from the administration of the premedication.]

    VAS (Visual Analogue Score) Anxiety Scale is a 100 mm long scale. The scale is marked in millimeters from 0 to 100, where 0 correlates with no anxiety at all, and 100 correlates to anxiety as bad as possible. The maximum score is 100 and minimum 0. The patient is asked to point on the scale according to his anxiety level. The more the reduction in anxiety from baseline, the better the outcome.

  2. Change in anxiety score based on The Amsterdam Preoperative Anxiety and Information Scale (APAIS) between treatment arms [Before administration of premedication, and after 1 hour from the administration of the premedication.]

    The Amsterdam Preoperative Anxiety and Information Scale (APAIS) is a self-reported questionnaire. The scale consists of six items, four of which assess the patient's anxiety, while the last two assess the patients' need-for-information and the patient must choose how much he agrees with each item on a scale of 1 (not at all) to 5 (very much). The more the reduction in the anxiety score from baseline the better the outcome.

Secondary Outcome Measures

  1. Change in sedation between treatment arms [Before administration of premedication, and after 1 hour from the administration of the premedication.]

    Sedation will be assessed with Ramsay sedation scale (RSS) as follows: - Patient is anxious and agitated or restless, or both - Patient is cooperative, oriented, and tranquil - Patient responds to commands only - Patient exhibits brisk response to light glabellar tap or loud auditory stimulus - Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus - Patient exhibits no response.

  2. Change in orientation between treatment arms [Before administration of premedication, and after 1 hour from the administration of the premedication.]

    Orientation will be assessed with a three-point scale as follows: 0 - None - Orientation in either time or place - Orientation in both

Other Outcome Measures

  1. Change in the anxiety score using the visual analogue score for anxiety between genders [Before administration of premedication, and after 1 hour from the administration of the premedication.]

    VAS (Visual Analogue Score) Anxiety Scale is a 100 mm long scale. The scale is marked in millimeters from 0 to 100, where 0 correlates with no anxiety at all, and 100 correlates to anxiety as bad as possible. The maximum score is 100 and minimum 0. The patient is asked to point on the scale according to his anxiety level. The more the reduction in anxiety from baseline, the better the outcome.

  2. Change in anxiety score based on The Amsterdam Preoperative Anxiety and Information Scale (APAIS) between genders [Before administration of premedication, and after 1 hour from the administration of the premedication.]

    The Amsterdam Preoperative Anxiety and Information Scale (APAIS) is a self-reported questionnaire. The scale consists of six items, four of which assess the patient's anxiety, while the last two assess the patients' need-for-information and the patient must choose how much he agrees with each item on a scale of 1 (not at all) to 5 (very much). The more the reduction in the anxiety score from baseline the better the outcome.

  3. Change in sedation between genders [Before administration of premedication, and after 1 hour from the administration of the premedication.]

    Sedation will be assessed with Ramsay sedation scale (RSS) as follows: - Patient is anxious and agitated or restless, or both - Patient is cooperative, oriented, and tranquil - Patient responds to commands only - Patient exhibits brisk response to light glabellar tap or loud auditory stimulus - Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus - Patient exhibits no response.

  4. Change in orientation between genders [Before administration of premedication, and after 1 hour from the administration of the premedication.]

    Orientation will be assessed with a three-point scale as follows: 0 - None - Orientation in either time or place - Orientation in both

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA 1 or 2

  • Posted for general anesthesia

  • Aging between 18 and 65 years

Exclusion Criteria:
  • Allergy to any of the drugs under study

  • Pregnancy

  • Illiteracy

  • Any mental illness

  • Taking antipsychotics, antidepressants, anxiolytics, or sedatives

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jordan University Hospital Amman Jordan

Sponsors and Collaborators

  • University of Jordan

Investigators

  • Principal Investigator: Omar Ismail, University of Jordan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Omar Ismail, Principle Investigator, University of Jordan
ClinicalTrials.gov Identifier:
NCT06103188
Other Study ID Numbers:
  • M001
First Posted:
Oct 26, 2023
Last Update Posted:
Oct 27, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Omar Ismail, Principle Investigator, University of Jordan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2023